Genmab ADR (NASDAQ: GMAB) is -5.75% lower on its value in year-to-date trading and has touched a low of $19.02 and a high of $31.88 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GMAB stock was last observed hovering at around $19.81 in the last trading session, with the day’s loss setting it -0.14%.
Currently trading at $19.67, the stock is -6.64% and -6.19% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.32 million and changing -0.71% at the moment leaves the stock -21.28% off its SMA200. GMAB registered -30.07% loss for a year compared to 6-month loss of -30.47%. The firm has a 50-day simple moving average (SMA 50) of $20.9684 and a 200-day simple moving average (SMA200) of $24.9878.
The stock witnessed a -5.30% gain in the last 1 month and extending the period to 3 months gives it a -14.92%, and is -6.91% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.49% over the week and 2.16% over the month.
Genmab ADR (GMAB) has around 2204 employees, a market worth around $12.50B and $2.87B in sales. Current P/E ratio is 18.95 and Fwd P/E is 14.80. Profit margin for the company is 23.49%. Distance from 52-week low is 3.42% and -38.30% from its 52-week high. The company has generated returns on investments over the last 12 months (13.73%).
with sales reaching $6.36B over the same period.The EPS is expected to grow by 26.19% this year, but quarterly earnings will post 28.40% year-over-year. Quarterly sales are estimated to grow 35.90% in year-over-year returns.
Genmab ADR (GMAB) Top Institutional Holders
The shares outstanding are 635.14M, and float is at 635.07M with Short Float at 0.27%.
The top institutional shareholder in the company is ALLIANCEBERNSTEIN L.P. with over 15.24 million shares valued at $382.93 million. The investor’s holdings represent 23.334% of the GMAB Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.08 million shares valued at $127.67 million to account for 7.78 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 4.23 million shares representing 6.4744% and valued at over $108.15 million, while HARDING LOEVNER LP holds 4.2384 of the shares totaling 2.77 million with a market value of $69.61 million.
Genmab ADR (GMAB) Insider Activity
#####
